CD274 and neoplasm: The immunosuppressive tumor microenvironment can activate the PD-1/PD-L1 signaling pathway, and blocking the PD-1/PD-L1 signaling pathway reverses the tumor immune microenvironment and increases the body's immune system's capability of killing the cancerous cells.